Engineering T-Cells
To dramatically reduce costs off-the-shelf CAR-T cells. The off-the shelf path would preempt the very costly ($500,000) , laborious and time consuming work of autologous CAR-T, produced from the patient’s own cells.
Krishna Bala, Ph.D.
I am an engineering leader creating technology solutions that accelerate cancer research and diagnosis.
You may also enjoy
Founder Mode
Paul Graham’s blog discusses Founder mode versus Manager mode: What it takes to build a successful scalable company!
Google DeepMind’s new AlphaFold can model a much larger slice of biological life
The already amazing AlphaFold 2 AI system only knew about amino acids, but now, AlphaFold 3 can in principle predict where a drug binds to a protein!
Engineers and Tech Leaders Looking to Learn And Grow
Great perspective and advice for engineers and tech leaders on growing, learning and contributing!
How to Create a Culture Of Performance in Teams
A great episode on significantly accelerating innovation using “Tiger Teams”. An OKRs focus is not sufficient!